1Department of Nursing, Samsung Medical Center, Seoul, Korea.
2Department of Nursing Science, Woo Suk University, Wanju, Korea.
3Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea.
4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Copyright © 2014 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Those who do not have any muscular or neural diseases at the sites of insulin injection on the abdomen and upper arm
Those who do not have any skin damage, such as wart, contusion, or brush-burns, at the sites of ultrasound measurements on the abdomen and upper arm
Those who are not using an insulin pump at the sites of ultrasound measurements on the abdomen and upper arm
Those who do not have diseases that may affect the skin thickness, such as malignant tumor or collagen diseases
Those who were not treated with steroids for a prolonged period of time
Those who have fully understood the objectives of this research and can communicate, as well as being able to sign the agreements to participate
This work was partially supported by the Becton Dickinson and Company, but no potential conflict of interest relevant to this article was reported.